Treatment of COVID‐19 patients with the anti‐CD6 antibody itolizumab-Reference-Cited by-同舟云学术

Treatment of COVID‐19 patients with the anti‐CD6 antibody itolizumab

Published:2020-01 Issue:11 Volume:9 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin. Transl. Immunol.

Author:

Caballero Armando¹,Filgueira Lázaro M²,Betancourt Julio²,Sánchez Naivy²,Hidalgo Carlos²,Ramírez Alberto³,Martinez Alejandro³,Despaigne Rolando E⁴,Escalona Alberto⁵,Diaz Henrry⁶,Meriño Elio⁶,Ortega Lilia M⁷,Castillo Ulises⁸,Ramos Mayra⁹,Saavedra Danay⁹,García Yanelda⁹,Lorenzo Geydi⁹,Cepeda Meylán⁹,Arencibia Maylén⁹,Cabrera Leticia⁹,Domecq Milagros⁹,Estévez Daymys⁹,Valenzuela Carmen⁹,Lorenzo Patricia⁹,Sánchez Lizet⁹,Mazorra Zaima⁹,León Kalet¹⁰,Crombet Tania⁹^ORCID

Affiliation:

1. Intensive Care Unit Arnaldo Milián Castro University Hospital Santa Clara Cuba

2. Intensive Care Unit Manuel “Piti” Fajardo Rivero Hospital Santa Clara Cuba

3. Intensive Care Unit Salvador Allende Hospital Havana Cuba

4. Intensive Care Unit Joaquín Castillo Hospital Havana Cuba

5. Intensive Care Unit Faustino Pérez Hospital Matanzas Cuba

6. Intensive Care Unit Frank País Hospital Havana Cuba

7. Intensive Care Unit Pedro Kouri Institute Havana Cuba

8. Emergency Department Ministry of Cuban Health Havana Cuba

9. Clinical Research Direction Center of Molecular Immunology (CIM) Havana Cuba

10. Research Direction Center of Molecular Immunology (CIM) Havana Cuba

Publisher